|
業務類別
|
Biotechnology |
|
業務概覽
|
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion. |
| 公司地址
| 321 Harrison Avenue, Boston, MA, USA, 02118 |
| 電話號碼
| +1 617 221-9059 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.pyxisoncology.com |
| 員工數量
| 50 |
| Mr. Jitendra Wadhane |
Principal Financial Officer, Chief Accounting Officer and Senior Vice President, Finance |
-- |
03/07/2025 |
| Mr. Thomas Civik |
Director and Interim Chief Executive Officer |
-- |
06/02/2026 |
|
|
| Dr. Jakob Dupont, M.D.,PhD |
Independent Director |
29/04/2025 |
| Dr. Lara S. Sullivan, M.D. |
Director |
06/02/2026 |
| Mr. Thomas Civik |
Director and Interim Chief Executive Officer |
06/02/2026 |
| Mr. Darren S. Cline, M.B.A. |
Independent Director |
29/04/2025 |
| Dr. Rachel Humphrey, M.D. |
Independent Director |
29/04/2025 |
| Dr. Santhosh Palani, C.F.A.,PhD |
Independent Director |
29/04/2025 |
| Dr. Freda C. Lewis-Hall,M.D. |
Independent Director |
29/04/2025 |
| Mr. John L. Flavin |
Chairman of the Board |
29/04/2025 |
| Mr. Michael A. Metzger |
Independent Director |
29/04/2025 |
|
|
|
|
